(MZTI) The Marzetti - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 3.154m USD | Total Return: -30.4% in 12m
Avg Turnover: 41.5M
EPS Trend: 85.4%
Qual. Beats: -1
Rev. Trend: 95.6%
Warnings
Earnings expected to drop: P/E 18.0 → Forward 36.1
Below Avwap Earnings
Tailwinds
No distinct edge detected
The Marzetti Company (NASDAQ: MZTI), formerly Lancaster Colony Corporation, is a Westerville, Ohio-based manufacturer of specialty food products. The company operates through Retail and Foodservice segments, producing a diverse portfolio of branded frozen breads, refrigerated dressings, dips, and croutons. Key proprietary brands include New York Bakery, Sister Schubert’s, and Marzetti.
A significant portion of the business model relies on strategic licensing agreements with major national restaurant chains. Marzetti manufactures and distributes retail versions of sauces and dressings for brands such as Chick-fil-A, Buffalo Wild Wings, and Olive Garden. This model allows the company to leverage established restaurant brand equity to capture market share in high-traffic retail grocery aisles.
The specialty food sector is characterized by high consumer loyalty and lower price sensitivity compared to commodity staples. To better understand how these licensing partnerships impact long-term margins, you may want to review the detailed financial metrics available on ValueRay. Distribution is managed through a multi-channel network of direct sales personnel, food brokers, and distributors serving retailers and foodservice providers across the United States.
- Licensing growth for Chick-fil-A and Olive Garden sauces drives high-margin revenue
- Raw material inflation for eggs and soybean oil impacts manufacturing margins
- Consolidation of retail shelf space for specialty dressings affects segment volume
- Foodservice demand fluctuations from national restaurant chains influence quarterly earnings
- Expansion of frozen bread production capacity scales long-term operating efficiency
| Net Income: 175.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 3.26 > 1.0 |
| NWC/Revenue: 16.24% < 20% (prev 13.43%; Δ 2.81% < -1%) |
| CFO/TA 0.23 > 3% & CFO 316.8m > Net Income 175.8m |
| Net Debt (-181.2m) to EBITDA (296.2m): -0.61 < 3 |
| Current Ratio: 2.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.4m) vs 12m ago -0.43% < -2% |
| Gross Margin: 24.19% > 18% (prev 0.24%; Δ 2.40k% > 0.5%) |
| Asset Turnover: 147.4% > 50% (prev 147.8%; Δ -0.38% > 0%) |
| Interest Coverage Ratio: 164.6 > 6 (EBITDA TTM 296.2m / Interest Expense TTM 1.38m) |
| A: 0.23 (Total Current Assets 513.9m - Total Current Liabilities 198.9m) / Total Assets 1.36b |
| B: 1.25 (Retained Earnings 1.69b / Total Assets 1.36b) |
| C: 0.17 (EBIT TTM 227.3m / Avg Total Assets 1.32b) |
| D: 5.97 (Book Value of Equity 1.86b / Total Liabilities 311.3m) |
| Altman-Z'' = 13.02 = AAA |
| DSRI: 0.89 (Receivables 98.3m/106.9m, Revenue 1.94b/1.89b) |
| GMI: 0.98 (GM 24.19% / 23.70%) |
| AQI: 0.96 (AQ_t 0.18 / AQ_t-1 0.19) |
| SGI: 1.03 (Revenue 1.94b / 1.89b) |
| TATA: -0.10 (NI 175.8m - CFO 316.8m) / TA 1.36b) |
| Beneish M = -3.24 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 114.27 with a total of 490,168 shares traded.
Over the past week, the price has changed by +1.14%,
over one month by -10.45%,
over three months by -30.30% and
over the past year by -30.43%.
The Marzetti has no consensus analysts rating.
P/E Trailing = 17.9969
P/E Forward = 36.1011
P/S = 1.6254
P/B = 3.0184
P/EG = 3.1204
Revenue TTM = 1.94b USD
EBIT TTM = 227.3m USD
EBITDA TTM = 296.2m USD
Long Term Debt = unknown (none)
Short Term Debt = 11.7m USD (from shortTermDebt, last fiscal year)
Debt = 37.2m USD (from shortLongTermDebtTotal, last quarter) (leases 37.2m already included)
Net Debt = -181.2m USD (calculated: Debt 37.2m - CCE 218.4m)
Enterprise Value = 2.97b USD (3.15b + Debt 37.2m - CCE 218.4m)
Interest Coverage Ratio = 164.6 (Ebit TTM 227.3m / Interest Expense TTM 1.38m)
EV/FCF = 11.99x (Enterprise Value 2.97b / FCF TTM 248.0m)
FCF Yield = 8.34% (FCF TTM 248.0m / Enterprise Value 2.97b)
FCF Margin = 12.78% (FCF TTM 248.0m / Revenue TTM 1.94b)
Net Margin = 9.06% (Net Income TTM 175.8m / Revenue TTM 1.94b)
Gross Margin = 24.19% ((Revenue TTM 1.94b - Cost of Revenue TTM 1.47b) / Revenue TTM)
Gross Margin QoQ = 23.65% (prev 26.50%)
Tobins Q-Ratio = 2.19 (Enterprise Value 2.97b / Total Assets 1.36b)
Interest Expense / Debt = 3.71% (Interest Expense 1.38m / Debt 37.2m)
Taxrate = 23.31% (11.3m / 48.3m)
NOPAT = 174.3m (EBIT 227.3m * (1 - 23.31%))
Current Ratio = 2.58 (Total Current Assets 513.9m / Total Current Liabilities 198.9m)
Debt / Equity = 0.04 (Debt 37.2m / totalStockholderEquity, last quarter 1.04b)
Debt / EBITDA = -0.61 (Net Debt -181.2m / EBITDA 296.2m)
Debt / FCF = -0.73 (Net Debt -181.2m / FCF TTM 248.0m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.36% (Net Income 175.8m / Total Assets 1.36b)
RoE = 17.35% (Net Income TTM 175.8m / Total Stockholder Equity 1.01b)
RoCE = 19.65% (EBIT 227.3m / Capital Employed (Total Assets 1.36b - Current Liab 198.9m))
RoIC = 17.83% (NOPAT 174.3m / Invested Capital 977.7m)
WACC = 6.46% (E(3.15b)/V(3.19b) * Re(6.50%) + D(37.2m)/V(3.19b) * Rd(3.71%) * (1-Tc(0.23)))
Discount Rate = 6.50% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -6.67 | Cagr: -0.10%
[DCF] Terminal Value 77.97% ; FCFF base≈225.5m ; Y1≈258.5m ; Y5≈380.5m
[DCF] Fair Price = 215.4 (EV 5.73b - Net Debt -181.2m = Equity 5.91b / Shares 27.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 85.43 | EPS CAGR: 7.93% | SUE: -3.85 | # QB: -1
Revenue Correlation: 95.64 | Revenue CAGR: 2.09% | SUE: N/A | # QB: 0
EPS next Quarter (2026-09-30): EPS=1.78 | Chg30d=-1.66% | Revisions=-33% | Analysts=3
EPS current Year (2026-06-30): EPS=6.77 | Chg30d=-3.45% | Revisions=-50% | GrowthEPS=+0.7% | GrowthRev=+0.9%
EPS next Year (2027-06-30): EPS=7.22 | Chg30d=-1.96% | Revisions=-50% | GrowthEPS=+6.6% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: -50%